
Pharma Pulse 1/16/25: 5 Predictions That Will Drive R&D Effectiveness in 2025, Key Drugs to Watch for Community Pharmacy & more
The latest news for pharma industry insiders.
A focus on data and process excellence advances product development.
These drugs are set to revolutionize their respective disease states in 2025.
The term helps business technology leaders justify the high cost of artificial intelligence.
Happen Ventures, a leader in beneficial reuse, has partnered with Honest Medical to address their excess inventory problem through their innovative Beneficial Reuse Program. This initiative enabled Honest Medical to donate surplus medical supplies to local nonprofits like Hope Esperanza.
In a recent interview with Pharmaceutical Executive, our founder & CEO Peter Ax, uncovered how #telehealth is evolving to meet complex healthcare needs. From streamlining prior authorizations to leveraging AI for enhanced patient care, UpScriptHealth is working to reduce administrative burdens and improve access to medications.
#DigitalHealth #Healthcare
Have news you want us to share in Pharma Pulse? Reach out to Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

